Skip to main content
Premium Trial:

Request an Annual Quote

Rubicon Inks Distribution Deals in Europe, Asia-Pacific, Middle East

NEW YORK (GenomeWeb News) – Rubicon Genomics today announced several distribution deals for its nucleic acid library preparation products in Europe, the Asia-Pacific region, and the Middle East.

The Ann Arbor, Mich.-based firm has signed deals with Amplitech to distribute its products in France; HPST for the Czech Republic; and LuBio Science for Switzerland. In Asia agreements were reached with Recenttec covering Japan; Prisma Biotech for Taiwan, and S.M. Chemical for Thailand, while in Australia and New Zealand Custom Science will be a Rubicon distributor.

Lastly, in Qatar Rubicon said an unidentified local biomedical distributor will be supporting the firm's sales.

Financial and other terms of the deals were not disclosed.

In a statement, Rubicon CEO James Koziarz said the agreements extend his company's "reach in growing sequencing markets around the globe and enable our customers to access our products without the additional cost and complications of shipping from the US to global destinations."

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.